REGN vs GOOGL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

GOOGL has stronger fundamentals based on our AI analysis.

REGN
REGENERON PHARMACEUTICALS, INC.
BUY
80%
Confidence
VS
GOOGL
Alphabet Inc.
BUY
91%
Confidence

REGN vs GOOGL Fundamental Comparison

Metric REGN GOOGL
Revenue $14.3B $402.8B
Net Income $4.5B $132.2B
Net Margin 31.4% 32.8%
ROE 14.4% 31.8%
ROA 11.1% 22.2%
Current Ratio 4.13x 2.01x
Debt/Equity 0.06x 0.12x
EPS $41.48 $10.81

Green = Better metric | Red = Weaker metric

View Full REGN Analysis →
View Full GOOGL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

REGN vs AAPL GOOGL vs MSFT REGN vs AMZN GOOGL vs NVDA

REGN vs GOOGL: Frequently Asked Questions

Is REGN or GOOGL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), GOOGL has stronger fundamentals. REGN is rated BUY (80% confidence) while GOOGL is rated BUY (91% confidence). This is not investment advice.

How does REGN compare to GOOGL fundamentally?

REGENERON PHARMACEUTICALS, INC. has ROE of 14.4% vs Alphabet Inc.'s 31.8%. Net margins are 31.4% vs 32.8% respectively.

Which stock pays higher dividends, REGN or GOOGL?

REGN has a dividend yield of N/A or no dividend while GOOGL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in REGN or GOOGL for long term?

For long-term investing, consider that REGN has BUY rating with 80% confidence, while GOOGL has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about REGN vs GOOGL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs GOOGL, the AI consensus favors GOOGL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.